Model-informed approach to support pediatric dosing for the pan-PI3K inhibitor copanlisib in children and adolescents with relapsed/refractory solid tumors.
Saved in:
| Title: | Model-informed approach to support pediatric dosing for the pan-PI3K inhibitor copanlisib in children and adolescents with relapsed/refractory solid tumors. |
|---|---|
| Authors: | Morcos PN; Bayer HealthCare Pharmaceuticals, Inc., Whippany, New Jersey, USA., Schlender J; Pharmacometrics/Modeling & Simulation, Pharmaceuticals Division, Bayer AG, Wuppertal, Germany., Burghaus R; Pharmacometrics/Modeling & Simulation, Pharmaceuticals Division, Bayer AG, Wuppertal, Germany., Moss J; BAST Inc. Limited, Leicester, UK., Lloyd A; BAST Inc. Limited, Leicester, UK., Childs BH; Bayer HealthCare Pharmaceuticals, Inc., Whippany, New Jersey, USA., Macy ME; Department of Pediatrics, University of Colorado and Center for Cancer and Blood Disorders, Children's Hospital Colorado, Aurora, Colorado, USA., Reid JM; Department of Pharmacology, Mayo Clinic Graduate School of Biomedical Sciences, Rochester, Minnesota, USA., Chung J; Bayer HealthCare Pharmaceuticals, Inc., Whippany, New Jersey, USA., Garmann D; Pharmacometrics/Modeling & Simulation, Pharmaceuticals Division, Bayer AG, Wuppertal, Germany. |
| Source: | Clinical and translational science [Clin Transl Sci] 2023 Jul; Vol. 16 (7), pp. 1197-1209. Date of Electronic Publication: 2023 Apr 18. |
| Publication Type: | Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: WileyBlackwell Pub Country of Publication: United States NLM ID: 101474067 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1752-8062 (Electronic) Linking ISSN: 17528054 NLM ISO Abbreviation: Clin Transl Sci Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 37042099 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Model-informed approach to support pediatric dosing for the pan-PI3K inhibitor copanlisib in children and adolescents with relapsed/refractory solid tumors. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Morcos+PN%22">Morcos PN</searchLink>; Bayer HealthCare Pharmaceuticals, Inc., Whippany, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Schlender+J%22">Schlender J</searchLink>; Pharmacometrics/Modeling & Simulation, Pharmaceuticals Division, Bayer AG, Wuppertal, Germany.<br /><searchLink fieldCode="AU" term="%22Burghaus+R%22">Burghaus R</searchLink>; Pharmacometrics/Modeling & Simulation, Pharmaceuticals Division, Bayer AG, Wuppertal, Germany.<br /><searchLink fieldCode="AU" term="%22Moss+J%22">Moss J</searchLink>; BAST Inc. Limited, Leicester, UK.<br /><searchLink fieldCode="AU" term="%22Lloyd+A%22">Lloyd A</searchLink>; BAST Inc. Limited, Leicester, UK.<br /><searchLink fieldCode="AU" term="%22Childs+BH%22">Childs BH</searchLink>; Bayer HealthCare Pharmaceuticals, Inc., Whippany, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Macy+ME%22">Macy ME</searchLink>; Department of Pediatrics, University of Colorado and Center for Cancer and Blood Disorders, Children's Hospital Colorado, Aurora, Colorado, USA.<br /><searchLink fieldCode="AU" term="%22Reid+JM%22">Reid JM</searchLink>; Department of Pharmacology, Mayo Clinic Graduate School of Biomedical Sciences, Rochester, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Chung+J%22">Chung J</searchLink>; Bayer HealthCare Pharmaceuticals, Inc., Whippany, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Garmann+D%22">Garmann D</searchLink>; Pharmacometrics/Modeling & Simulation, Pharmaceuticals Division, Bayer AG, Wuppertal, Germany. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101474067%22">Clinical and translational science</searchLink> [Clin Transl Sci] 2023 Jul; Vol. 16 (7), pp. 1197-1209. <i>Date of Electronic Publication: </i>2023 Apr 18. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22WileyBlackwell+Pub%22">WileyBlackwell Pub </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101474067 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1752-8062 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217528054%22">17528054 </searchLink><i>NLM ISO Abbreviation: </i>Clin Transl Sci <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37042099 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1111/cts.13523 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1197 Titles: – TitleFull: Model-informed approach to support pediatric dosing for the pan-PI3K inhibitor copanlisib in children and adolescents with relapsed/refractory solid tumors. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Morcos PN – PersonEntity: Name: NameFull: Schlender J – PersonEntity: Name: NameFull: Burghaus R – PersonEntity: Name: NameFull: Moss J – PersonEntity: Name: NameFull: Lloyd A – PersonEntity: Name: NameFull: Childs BH – PersonEntity: Name: NameFull: Macy ME – PersonEntity: Name: NameFull: Reid JM – PersonEntity: Name: NameFull: Chung J – PersonEntity: Name: NameFull: Garmann D IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 07 Text: 2023 Jul Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 1752-8062 Numbering: – Type: volume Value: 16 – Type: issue Value: 7 Titles: – TitleFull: Clinical and translational science Type: main |
| ResultId | 1 |
